Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 28-year-old woman presents to the clinic reporting an absence of menses for the past six months. Her menstrual cycles were previously regular, occurring every 28 days and lasting 5 days. Her body mass index is 23 kg/m². She has no significant past medical history, takes no medications, and uses condoms for contraception. Vital signs are within normal limits. Physical examination reveals normal breast development and female hair distribution. There is no galactorrhea, hirsutism, or thyromegaly. Place the following diagnostic steps in the most appropriate chronological sequence for the initial evaluation of this patient's secondary amenorrhea.

  1. 1Perform a urine beta-human chorionic gonadotropin test
  2. 2Measure serum thyroid-stimulating hormone and prolactin levels
  3. 3Administer a 10-day course of oral medroxyprogesterone acetate
  4. 4Measure serum follicle-stimulating hormone level

Cevap

The correct chronological sequence is: 1) Perform a urine beta-human chorionic gonadotropin test, 2) Measure serum thyroid-stimulating hormone and prolactin levels, 3) Administer a 10-day course of oral medroxyprogesterone acetate, 4) Measure serum follicle-stimulating hormone level.
The evaluation of secondary amenorrhea is designed to rule out causes from most to least common, while avoiding unnecessary or expensive tests early in the workup. First, pregnancy must always be excluded using a beta-hCG test. Once pregnancy is ruled out, thyroid dysfunction and hyperprolactinemia are evaluated with TSH and prolactin levels, as these are common and easily treatable conditions. If these initial labs are normal, a progestin challenge test (e.g., medroxyprogesterone acetate) is administered to check for adequate endogenous estrogen production and a patent outflow tract. If the patient experiences withdrawal bleeding, the diagnosis is typically anovulation (e.g., PCOS). If the patient does not experience withdrawal bleeding, it implies hypoestrogenism or an anatomical defect. At this point, measuring FSH determines if the defect is at the level of the ovary (hypergonadotropic, indicating primary ovarian insufficiency) or the hypothalamus/pituitary (hypogonadotropic, indicating functional hypothalamic amenorrhea or a central lesion).

Adım Adım Çözüm

1
Rule out pregnancy
Perform a urine beta-human chorionic gonadotropin test
Pregnancy is the most common cause of secondary amenorrhea and must always be excluded before proceeding with further endocrinologic workup.
2
Rule out systemic endocrine disorders
Measure serum thyroid-stimulating hormone and prolactin levels
Hypothyroidism and hyperprolactinemia are common, easily treatable causes of secondary amenorrhea that can suppress the hypothalamic-pituitary-ovarian axis.
3
Assess estrogen status and outflow tract patency
Administer a 10-day course of oral medroxyprogesterone acetate
A progestin withdrawal challenge determines if the endometrium is primed by adequate endogenous estrogen and if the reproductive outflow tract is patent.
4
Determine the level of the hypothalamic-pituitary-ovarian axis defect
Measure serum follicle-stimulating hormone level
If the progestin challenge is negative (no bleeding), measuring FSH differentiates between primary ovarian insufficiency (high FSH) and functional hypothalamic amenorrhea or pituitary disease (low/normal FSH).

Anahtar Kavram

The step-wise diagnostic evaluation of secondary amenorrhea begins with ruling out pregnancy, followed by identifying systemic endocrinopathies (thyroid/prolactin), and then assessing the hypothalamic-pituitary-ovarian axis and outflow tract using a progestin challenge and gonadotropin levels.
Tahmini Süre:1m 30s
Bu soruyu puanla